AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $287,000 | -32.3% | 8,198 | +3.3% | 0.04% | -37.5% |
Q2 2020 | $424,000 | +88.4% | 7,934 | +25.1% | 0.06% | +36.6% |
Q1 2020 | $225,000 | -82.0% | 6,340 | -75.7% | 0.04% | -78.9% |
Q4 2019 | $1,248,000 | +73.6% | 26,131 | +17.7% | 0.19% | +56.5% |
Q3 2019 | $719,000 | -51.8% | 22,200 | -25.8% | 0.12% | -40.4% |
Q2 2019 | $1,491,000 | -26.0% | 29,900 | 0.0% | 0.21% | -17.5% |
Q1 2019 | $2,016,000 | +27.1% | 29,900 | -13.1% | 0.25% | +31.9% |
Q4 2018 | $1,586,000 | -40.2% | 34,400 | 0.0% | 0.19% | -24.5% |
Q3 2018 | $2,653,000 | +16.2% | 34,400 | +26.9% | 0.25% | +9.5% |
Q2 2018 | $2,283,000 | +3.0% | 27,100 | 0.0% | 0.23% | +8.5% |
Q1 2018 | $2,216,000 | +18.9% | 27,100 | -16.9% | 0.21% | +22.4% |
Q4 2017 | $1,864,000 | -78.7% | 32,600 | -75.1% | 0.17% | -76.0% |
Q3 2017 | $8,731,000 | +10.1% | 130,800 | -15.1% | 0.73% | +6.1% |
Q2 2017 | $7,928,000 | -11.3% | 154,100 | +0.7% | 0.68% | -11.3% |
Q1 2017 | $8,941,000 | +31.9% | 153,100 | -5.8% | 0.77% | +24.0% |
Q4 2016 | $6,781,000 | -12.9% | 162,500 | +10.2% | 0.62% | -5.6% |
Q3 2016 | $7,786,000 | +26.1% | 147,400 | 0.0% | 0.66% | +25.3% |
Q2 2016 | $6,175,000 | +30.3% | 147,400 | +26.3% | 0.53% | +30.8% |
Q1 2016 | $4,738,000 | -37.5% | 116,700 | 0.0% | 0.40% | -37.2% |
Q4 2015 | $7,576,000 | +32.0% | 116,700 | +43.5% | 0.64% | +24.5% |
Q3 2015 | $5,739,000 | -31.6% | 81,300 | +7.7% | 0.51% | -17.2% |
Q2 2015 | $8,391,000 | +2.6% | 75,500 | -12.9% | 0.62% | +4.5% |
Q1 2015 | $8,176,000 | -18.3% | 86,700 | -2.9% | 0.59% | -3.9% |
Q4 2014 | $10,005,000 | – | 89,300 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |